The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing. Continuous processing for the production of key building blocks and intermediates for ...

At the heart of modern finance beats a paradox. Every innovation aimed at speed and efficiency collides with an expanding web of regulation. What was designed to make finance safer often slows it down ...

Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing. While most basic research occurs in academia, contributions from industry are also undeniably ...